Trial Profile
SEQUENTIAL DEFERASIROX-DEFERIPRONE VERSUS DEFERASIROX OR DEFERIPRONE MULTICENTRE RANDOMIZED TRIAL
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary) ; Deferiprone (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
- Acronyms ND
- 03 May 2018 New trial record